| 英文名称 |
中文名称 |
CAS号 |
操作 |
| JNK Inhibitor VIII |
JNK INHIBITOR VIII (TCS JNK 6O) |
894804-07-0 |
详细
|
| IQ-3 |
IQ 3 |
312538-03-7 |
详细
|
| Guggulsterone |
香胶甾酮 |
95975-55-6 |
详细
|
| BI-882370 |
BI 882370 |
1392429-79-6 |
详细
|
| WHI-P258 |
WHI-P258 |
21561-09-1 |
详细
|
| CMPD1 |
CMPD1 |
41179-33-3 |
详细
|
| AL 8697 |
AL 8697 |
1057394-06-5 |
详细
|
| JWG-071 |
JWG-071 |
2250323-50-1 |
详细
|
| Belvarafenib |
BELVARAFENIB |
1446113-23-0 |
详细
|
| SB-590885 |
5-[2-[4-[2-(二甲基氨基)乙氧基]苯基]-5-(4-吡啶基)-1H-咪唑-4-基]-2,3-二氢-1-茚酮肟 |
405554-55-4 |
详细
|
| Trametinib |
曲美替尼 |
871700-17-3 |
详细
|
| Trametinib (DMSO solvate) |
曲美替尼二甲亚砜 |
1187431-43-1 |
详细
|
| AZ 628 |
AZ 628 |
878739-06-1 |
详细
|
| AS601245 |
JNK INHIBITOR V CALBIOCHEM |
345987-15-7 |
详细
|
| AZD7624 |
AZD-7624; AZD 7624; AZD7624 |
1095004-78-6 |
详细
|
| Dilmapimod |
444606-18-2 |
444606-18-2 |
详细
|
| Talmapimod |
他匹莫德 |
309913-83-5 |
详细
|
| BI-D1870 |
BI-D1870 |
501437-28-1 |
详细
|
| Pluripotin |
PLURIPOTIN |
839707-37-8 |
详细
|
| Hypothemycin |
寄端霉素 |
76958-67-3 |
详细
|
| Brevilin A |
短叶老鹳草素A |
16503-32-5 |
详细
|
| β-Hydroxyisovalerylshikonin |
BETA-羟基异戊酰紫草素 |
7415-78-3 |
详细
|
| Astragaloside VI |
黄芪皂苷VI |
84687-45-6 |
详细
|
| Arnicolide D |
山金车内酯D |
34532-68-8 |
详细
|
| Garcinone C |
GARCINONE C |
76996-27-5 |
详细
|
| Coumermycin A1 |
香豆霉素 |
4434-05-3 |
详细
|
| Cetuximab |
西妥昔单抗 |
205923-56-4 |
详细
|
| Trastuzumab |
曲妥珠单抗 |
180288-69-1 |
详细
|
| Pertuzumab |
帕妥珠单抗 |
380610-27-5 |
详细
|
| ZD-4190 |
413599-62-9 |
413599-62-9 |
详细
|
| GNE-495 |
GNE-495 |
1449277-10-4 |
详细
|
| TBHQ |
特丁基对苯二酚 |
1948-33-0 |
详细
|
| M2698 |
M2698 |
1379545-95-5 |
详细
|
| RAF709 |
化合物RAF709 |
1628838-42-5 |
详细
|
| (E)-Necrosulfonamide |
N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 |
1360614-48-7 |
详细
|
| APS-2-79 |
2002381-25-9 |
2002381-25-9 |
详细
|
| NCB-0846 |
NCB-0846 |
1792999-26-8 |
详细
|
| GS-444217 |
ASK1-IN-1 |
1262041-49-5 |
详细
|
| LY3214996 |
LY3214996 |
1951483-29-6 |
详细
|
| TC13172 |
TCI3172 |
2093393-05-4 |
详细
|
| AX-15836 |
2035509-96-5 |
2035509-96-5 |
详细
|
| AD80 |
AD80 |
1384071-99-1 |
详细
|
| Sorafenib Tosylate |
甲苯磺酸索拉非尼 |
475207-59-1 |
详细
|
| BRAF inhibitor |
N-[2,4-二氟-3-[[5-(3-吡啶基)-1H-吡咯并[2,3-B]吡啶-3-基]羰基]苯基]-2-丙磺酰胺 |
918505-61-0 |
详细
|
| SB 203580 hydrochloride |
869185-85-3 |
869185-85-3 |
详细
|
| TC ASK 10 |
化合物 T13099 |
1005775-56-3 |
详细
|
| Regorafenib |
瑞格非尼 |
755037-03-7 |
详细
|
| Regorafenib monohydrate |
瑞格非尼一水合物 |
1019206-88-2 |
详细
|
| Sorafenib |
索拉非尼 |
284461-73-0 |
详细
|
| Reticuline |
牛心果鹼 |
485-19-8 |
详细
|
| Triacetylresveratrol |
乙酰化白藜芦醇 |
42206-94-0 |
详细
|
| Hispidulin |
高车前素 |
1447-88-7 |
详细
|
| Mogrol |
罗汉果醇 |
88930-15-8 |
详细
|
| Sulforaphene |
莱菔素 |
592-95-0 |
详细
|
| Ginsenoside Rk1 |
人参皂苷RK2 |
494753-69-4 |
详细
|
| SLV-2436 |
2095704-43-9 |
2095704-43-9 |
详细
|
| KO-947 |
KO-947 |
1695533-89-1 |
详细
|
| UM-164 |
UM-164 |
903564-48-7 |
详细
|
| EGFR Protein Tyrosine Kinase Substrate |
|
945830-38-6 |
详细
|
| ERK1/2 inhibitor 1 |
ERK1/2 INHIBITOR 1 |
2095719-90-5 |
详细
|
| GW806742X |
CS-2659 |
579515-63-2 |
详细
|
| ETC-206 |
4-[6-[4-(4-吗啉基羰基)苯基]咪唑并[1,2-A]吡啶-3-基]苄腈 |
1464151-33-4 |
详细
|
| MK-2 Inhibitor III |
MK-2 INHIBITOR III (COMPOUND 16) |
1186648-22-5 |
详细
|
| CC-90003 |
1621999-82-3 |
1621999-82-3 |
详细
|
| GW284543 |
GW284543 (UNC10225170) |
790186-68-4 |
详细
|
| DLK-IN-1 |
化合物 T11056 |
1620574-24-4 |
详细
|
| p38α inhibitor 1 |
P38Α INHIBITOR 1 |
1034189-82-6 |
详细
|
| AZ304 |
AZ304 |
942507-42-8 |
详细
|
| RRD-251 |
(2,4-二氯苯基)甲基硫基甲烷脒盐酸盐 |
72214-67-6 |
详细
|
| (rel)-AR234960 |
(rel)-AR234960 |
1408311-94-3 |
详细
|
| MW-150 |
MW-150 |
1628502-91-9 |
详细
|
| U0126-EtOH |
2,3-双[氨基[(2-氨基苯基)硫]亚甲基]丁二腈乙醇盐 |
1173097-76-1 |
详细
|
| Pimasertib |
N-[(2S)-2,3-二羟基丙基]-3-[(2-氟-4-碘苯基)氨基]-4-吡啶甲酰胺 |
1236699-92-5 |
详细
|
| BIX02188 |
(3Z)-3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯亚甲基]-2,3-二氢-2-氧代-1H-吲哚-6-甲酰胺 |
334949-59-6 |
详细
|
| BIX02189 |
BIX 02189 |
1265916-41-3 |
详细
|
| AZD8330 |
2-(2-氟-4-碘苯氨基)-N-(2-羟基乙氧基)-1,5-二甲基-6-氧代-1,6-二氢吡啶-3-甲酰胺 |
869357-68-6 |
详细
|
| AT7867 |
AT7867 |
857531-00-1 |
详细
|
| AT7867 dihydrochloride |
4-(4-氯苯基)-4-[4-(1H-吡唑-4-基)苯基]哌啶二盐酸盐 |
1431697-86-7 |
详细
|
| PD318088 |
5-溴-N-(2,3-二羟基丙氧基)-3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯甲酰胺 |
391210-00-7 |
详细
|
| FR 180204 |
FR180204 |
865362-74-9 |
详细
|
| HG6-64-1 |
CS-1301 |
1315329-43-1 |
详细
|
| Tpl2 Kinase Inhibitor 1 |
4-[(3-氯-4-氟苯基)氨基]-6-[(3-吡啶甲基)氨基]-1,7-萘啶-3-甲腈 |
871307-18-5 |
详细
|
| KY-05009 |
1228280-29-2 |
1228280-29-2 |
详细
|
| LY-2584702 tosylate salt |
LY2584702 TOSYLATE |
1082949-68-5 |
详细
|
| LY3009120 |
LY-3009120 |
1454682-72-4 |
详细
|
| ERK1/2 inhibitor 2 |
ASTX-029 |
2095719-92-7 |
详细
|
| 5Z-7-Oxozeaenol |
(5Z)-7-OXOZEAENOL |
253863-19-3 |
详细
|
| SR-3306 |
化合物SR-3306 |
1128096-91-2 |
详细
|
| ERK5-IN-2 |
ERK5-IN-2 |
1888305-96-1 |
详细
|
| p38 MAPK-IN-1 |
CS-2117 |
1006378-90-0 |
详细
|
| CCT196969 |
CB93134226 |
1163719-56-9 |
详细
|
| CC-401 hydrochloride |
3-[3-[2-(1-哌啶基)乙氧基]苯基]-5-(1H-1,2,4-三唑-5-基)-1H-吲唑盐酸盐 |
1438391-30-0 |
详细
|
| Cobimetinib hemifumarate |
可美替尼 |
1369665-02-0 |
详细
|
| 5,6,7-Trimethoxyflavone |
黄岑素-5,6,7-三甲醚 |
973-67-1 |
详细
|
| MK-8353 |
化合物 T12069 |
1184173-73-6 |
详细
|
| AZD-0364 |
CS-2696 |
2097416-76-5 |
详细
|
| DMX-5804 |
DMX5804;DMX 5804 |
2306178-56-1 |
详细
|
| PROTAC B-Raf degrader 1 |
PROTAC B-Raf degrader 1 |
2364367-27-9 |
详细
|
| LUT014 |
LUT-014 |
2274819-46-2 |
详细
|
| BAY885 |
BAY-885 |
2307249-33-6 |
详细
|